Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08887_nanopub.RA20UVBiddL7WotUNJjXqGmE2P3ockkVw0adbVGAlcyQY#assertion>. }
Showing items 1 to 19 of
19
with 100 items per page.
- drugbank:DB08887 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08887 label "Icosapent ethyl [drugbank:DB08887]" assertion.
- drugbank:DB08887 seeAlso DB08887 assertion.
- drugbank:DB08887 seeAlso icosapent-ethyl.html assertion.
- drugbank:DB08887 seeAlso vascepa-drug.htm assertion.
- drugbank:DB08887 identifier "drugbank:DB08887" assertion.
- drugbank:DB08887 description "Icosapent ethyl or ethyl eicosapentaenoic acid is a synthetic derivative of the omega-3 fatty acid eicosapentaenoic acid (EPA). It is used as adjunct therapy for severe hypertriglyceridemia (TG levels > 500 mg/dL). FDA approved on July 26, 2012." assertion.
- drugbank:DB08887 title "Icosapent ethyl" assertion.
- drugbank:DB08887 bio2rdf_vocabulary:identifier "DB08887" assertion.
- drugbank:DB08887 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08887 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08887" assertion.
- drugbank:DB08887 bio2rdf_vocabulary:x-identifiers.org DB08887 assertion.
- drugbank:DB08887 drugbank_vocabulary:drugbank-id "DB08887" assertion.
- drugbank:DB08887 drugbank_vocabulary:x-cas cas:86227-47-6 assertion.
- drugbank:DB08887 drugbank_vocabulary:x-ahfs ahfs:24:06.92 assertion.
- drugbank:DB08887 drugbank_vocabulary:x-kegg kegg:C16184 assertion.
- drugbank:DB08887 drugbank_vocabulary:x-kegg kegg:D01892 assertion.
- drugbank:DB08887 drugbank_vocabulary:x-wikipedia wikipedia:Ethyl_eicosapentaenoic_acid assertion.
- drugbank:DB08887 drugbank_vocabulary:x-ndc ndc:52937-001-04 assertion.